MoonLake Immunotherapeutics
MLTX
#3885
Rank
A$3.80 B
Marketcap
$60.12
Share price
-3.79%
Change (1 day)
-11.25%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -A$0.17 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$86.05 Million, an increase over its 2022 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.17 Billion86.51%
2023 -A$86.05 Million-16.81%
2022 -A$0.11 Billion